Nivanex Dmx
Product Images NDC 75834-040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nivanex Dmx (NDC 75834-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (60 Tablet Bottle Label)

Principal Display Panel (60 Tablet Bottle Label)
Nivanex DMX is a medicine that comes in a bottle containing 60 tablets. The medicine is a combination of Dextromethorphan and Gualfenesin, which serves as a cough suppressant and expectorant, respectively. It also contains Phenylephrine HCI, which helps to clear nasal congestion. It is used for the temporary relief of symptoms associated with the common cold, hay fever, or other upper respiratory allergies such as coughing, nasal congestion, and mucus discharges. The medication could be taken by adults and children above 12 years, depending on the recommended dosage. Person with certain health conditions, such as diabetes, heart disease, thyroid disease, high blood pressure, or trouble urinating due to an enlarged prostate gland should not use this medicine without seeking medical advice. The medicine may cause side effects, and its use should be stopped and replaced with medical attention if symptoms persist or develop new symptoms appear.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.